http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9686339161c3bea1c0c458414bdf882f
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Schwartz |
| name | Gary K Schwartz Gary K. Schwartz Gary. K. Schwartz |
| given-name | Gary K Gary. K. Gary K. |
| organization-name | Authors' Affiliations: 1Genitourinary Oncology Service, 2Melanoma and Sarcoma Service, and 3Gastrointestinal Oncology Service, Department of Medicine; 4Molecular Pharmacology and Chemistry Program, Sloan-Kettering Institute; 5Department of Radiology and 6Biostatistics Service, Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York 2Laboratory of New Drug Development, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA; Department of Medicine, Columbia University Medical Center New York New York From the Department of Medicine, Division of Solid Tumor Oncology, Gastrointestinal Oncology Section, Memorial Sloan-Kettering Cancer Center, New York, NY; and Quintiles, Kansas City, MO. Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA From the Department of Medicine, Division of Solid Tumor Oncology, Gastrointestinal Oncology Service, and The Laboratory of New Drug Development; Memorial Sloan- Kettering Cancer Center, New York, NY From The Molecular Therapeutics Program, the Sloan-Kettering Institute; the Department of Medicine, the Division of Hematology-Oncology and the Division of Solid Tumor Oncology, Memorial Sloan-Kettering Cancer Center; New York, NY; and the Division of Hematology and Oncology, the Department of Internal Medicine, Wayne State University School of Medicine, Karmanos Cancer Institute, Detroit, MI. 1Laboratory of New Drug Development, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York and Departments of Columbia University, New York, NY Memorial Sloan Kettering Cancer Center, 1275 York Avenue, NY 10065, USA Authors' Affiliations: 1Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania; 2Karmanos Cancer Institute, Detroit, Michigan; 3Pfizer Oncology, San Diego, California; and 4Memorial Sloan-Kettering Cancer Center, New York Seth M. Pollack, Fred Hutchinson Cancer Research Center; Seth M. Pollack and Matthew B. Spraker, University of Washington, Seattle, WA; and Matthew Ingham and Gary K. Schwartz, Columbia University School of Medicine, New York, NY. From the Memorial Sloan-Kettering Cancer Center, New York; North Shore University Hospital–New York University, Manhasset, NY; and Lilly Research Laboratories, Indianapolis, IN 3Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York Case Comprehensive Cancer Center Cleveland Ohio USA From the Sarcoma Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY; Division of Oncology, Washington University in St. Louis School of Medicine, St. Louis, MO; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY. Columbia University Medical Center; New York NY USA 2Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York. All authors: Memorial Sloan-Kettering Cancer Center, New York, NY. Columbia University Medical Center, New York, New York, USA Medicine 1Laboratory of New Drug Development, Department of Medicine, MSKCC and Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA Richard D. Carvajal and Gary K. Schwartz, Columbia University Medical Center; Paul B. Chapman and Alexander N. Shoushtari, Memorial Sloan Kettering Cancer Center, New York, NY; Sophie Piperno-Neumann and Manuel J. Rodrigues, Institut Curie, Paris; Lauris Gastaud, Centre Antoine-Lacassagne, Nice, France; Ellen Kapiteijn, Leiden University Medical Center, Leiden, the Netherlands; Stephen Frank, Hebrew University Hadassah Medical School – The Sharett Institute of Oncology, Jerusalem; Jacob Schachter, Sheba... for the COVID-19 and Cancer Consortium (CCC19) Herbert Irving Comprehensive Cancer Center of Columbia University New York NY USA; Columbia University Irving Medical Center New York NY USA Jyoti D. Patel, Northwestern University; Blasé Polite, University of Chicago Medicine, Chicago, IL; Lada Krilov, American Society of Clinical Oncology, Alexandria, VA; Sylvia Adams and William L. Carroll, New York University Cancer Institute; Carol Aghajanian, Mark G. Kris, and Gary K. Schwartz, Memorial Sloan-Kettering Cancer Center, New York, NY; Ethan Basch, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; Marcia S. Brose, University of Pennsylvania Abramson Cancer... Department of Medicine, Division of Hematology/Oncology, Columbia University Medical Center, New York, NY, USA Columbia University Medical Center, New York, New York 2Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Department of Medicine, Columbia University Irving Medical Center, New York, New York. Gregory Masters, Helen F. Graham Cancer Center, Newark, DE; Lada Krilov and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; Howard H. Bailey, University of Wisconsin Hospital and Clinics, Madison, WI; Marcia S. Brose, University of Pennsylvania Abramson Cancer Center, Philadelphia, PA; Harold Burstein and Lisa R. Diller, Dana-Farber Cancer Institute; Don S. Dizon, Massachusetts General Hospital, Boston, MA; Howard A. Fine, New York University Langone Medical Center; Gary K.... Authors' Affiliation: Jennifer Goodman Linn Laboratory of New Drug Development in Sarcoma and Rare Cancers, Memorial Sloan-Kettering Cancer Center, New York, New York Associate Editor, Journal of Clinical Oncology, Alexandria, VA; Columbia University, Vagelos College of Physicians and Surgeons, Herbert Irving Comprehensive Cancer Center, New York, NY; Case Comprehensive Cancer Center, Cleveland, OH Authors' Affiliations: 1Jennifer Goodman Linn Laboratory of New Drug Development, Department of Medicine; Departments of 2Cell Biology; and 3Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York 2Division of Hematology/Oncology, Department of Medicine, Columbia University, New York, New York.; 3Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York. Columbia University, New York, NY; Associate Editor, Journal of Clinical Oncology, Alexandria, VA From the Departments of Medicine, Pathology, Radiology, and Biostatistics and Epidemiology, Memorial Sloan-Kettering Cancer Center; Rockefeller University, New York, NY; Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago; Evanston Northwestern Health Care, Evanston, IL; Carolinas Hematology-Oncology and University of North Carolina, Charlotte, NC; Division of... All authors: Columbia University School of Medicine, New York, NY. Authors' Affiliations: 1The Human Oncology and Pathogenesis Program, Departments of 2Medicine, 3Pathology, 4Radiology, 5Dermatology, and 6Epidemiology & Biostatistics, and 7Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center; and 8The Ludwig Institute for Cancer Research, New York, New York Gastrointestinal Oncology Research Laboratory, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York Authors' Affiliations: 1Laboratory of New Drug Development, Department of Medicine, 2Department of Pathology, 3Human Oncology & Pathogenesis Program, Memorial Sloan-Kettering Cancer Center; and 4Department of Medicine, Weill Medical College of Cornell University, New York; Authors' Affiliations: 1Laboratory of New Drug Development, Department of Medicine, 2Department of Pathology, 3Human Oncology & Pathogenesis Program, Memorial Sloan-Kettering Cancer Center; and 4Department of Medicine, Weill Medical College of Cornell University, New York Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center, New York, New York. Authors' Affiliations: 1Laboratory of New Drug Development and Department of Medicine, and Departments of 2Molecular Pharmacology and Chemistry and 3Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York Jennifer Goodman Linn Laboratory of New Drug Development, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA Herbert Irving Comprehensive Cancer Center at Columbia University, New York, New York Columbia University Vagelos School of Medicine, Herbert Irving Comprehensive Cancer Center , New York, NY , USA Bruce J. Roth, Washington University in St Louis, St Louis, MO; Lada Krilov, American Society of Clinical Oncology, Alexandria, VA; Sylvia Adams, New York University; Carol A. Aghajanian, Peter Bach, Stuart M. Lichtman, and Gary K. Schwartz, Memorial Sloan-Kettering Cancer Center, New York, NY; Fadi Braiteh and Nicholas J. Vogelzang, US Oncology Research, Comprehensive Cancer Centers of Nevada; Wolfram Samlowski, US Oncology Research, Nevada Cancer Institute, Las Vegas, NV; Marcia S. Brose, University of... From the Department of Medicine, Divisions of Solid Tumor and Hematologic Oncology, Gastrointestinal Oncology Section, Memorial Sloan-Kettering Cancer Center, New York, NY, and Quintiles, Kansas City, MO. 1Division of Hematology and Oncology, Columbia University Irving Medical Center, New York, New York.; 2New York Presbyterian Hospital, Herbert Irving Pavilion, New York, New York.; 3Herbert Irving Comprehensive Cancer Center, New York, New York. From Memorial Sloan Kettering Cancer Center and Weill Cornell Medical Center (M.M.G., W.D.T., N.H., N.P.A., R.A.L., Y.M., R.Y.) and Columbia University Vagellos College of Physicians and Surgeons and New York Presbyterian Hospital (L.H.S., G.K.S.), New York, and Northwell Cancer Institute and Cold Spring Harbor Laboratory, Lake Success (R.G.M.) — all in New York; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN (M.R.M.); Washington University School of Medicine, St. Louis (B.A.V.T.); M.D.... 3Department of Medicine, Columbia University Medical Center, New York, New York From the Memorial Sloan-Kettering Cancer Center, New York, NY; Radiation Therapy Oncology Group Statistical Office; Thomas Jefferson University, Philadelphia, PA; M. D. Anderson Cancer Center, Houston, TX; Latter Day Saints Hospital, Salt Lake City, UT; Dayton Community Clinical Oncology Program, Dayton, OH; and Duke University Comprehensive Cancer Center, Durham, NC. Authors' Affiliations: 1Laboratory of New Drug Development, Department of Medicine and 2Department of Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York, New York Department of Medicine, Columbia University, New York, NY, USA From the Gastrointestinal Oncology Service, Division of Solid Tumor Oncology, Department of Medicine; Program of Molecular Pharmacology and Experimental Therapeutics; and Departments of Pediatrics and Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY Columbia University Herbert Irving Comprehensive Cancer Center, New York, New York 2Melanoma and Sarcoma Service, Division of Solid Tumor Oncology and; 3Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York Columbia University Irving Medical Center, New York, NY Department of Medicine Memorial Sloan‐Kettering Cancer Center New York New York Division of Hematology and Oncology, Department of Medicine, Columbia University Irving Medical Center, New York, NY Columbia University Vagelos School of Medicine, New York, NY 9Columbia University Herbert Irving Comprehensive Cancer Center, New York, New York. Authors' Affiliations: 1Medical Oncology Department, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona; 2Institute of Health Research INCLIVA, University of Valencia, Valencia; 3Hospital Virgen del Rocio, Seville, Spain; 4Dana-Farber Cancer Institute; 5Beth Israel Deaconess Medical Center, Boston; 6Alnylam Pharmaceuticals, Inc., Cambridge, Massachusetts; 7Karmanos Cancer Institute, Detroit, Michigan; 8Memorial Sloan-Kettering Cancer Center, New York, New York; 9Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona; and 10Sarah Cannon Research Institute, Nashville, Tennessee Don S. Dizon, Massachusetts General Hospital, Boston; Erica Mayer, Dana-Farber Cancer Institute, Boston, MA; Lada Krilov and Richard Schilsky, American Society of Clinical Oncology, Alexandria, VA; Ezra Cohen, University of California San Diego, San Diego; Patricia A. Ganz, University of California Los Angeles, Los Angeles; Sumanta Kumar Pal, City of Hope Comprehensive Cancer Center, Duarte, CA; Tara Gangadhar, University of Pennsylvania; Stephen Hunger, Children's Hospital Center of Philadelphia,... Laboratory of New Drug Development, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York From the Departments of Neurology (X.C., L.M.D., T.K.) and Medicine (G.K.S., R.D.C.), Memorial Sloan-Kettering Cancer Center, New York, NY. 3Division of Hematology/Oncology, Columbia University Medical Center, New York, New York. Authors' Affiliations: Departments of 1Medicine and 2Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York Laboratory of New Drug Development, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.; Melanoma and Sarcoma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. Division of Hematology/Oncology, Columbia University Medical Center, New York, New York, USA Memorial Sloan-Kettering Cancer Center, New York, NY Department of Medicine, Columbia University, New York, New York, USA Authors' Affiliations: 1Jennifer Goodman Linn Laboratory of New Drug Development, Department of Medicine, 2Department of Molecular Pharmacology and Chemistry, 3Department of Surgery, Memorial Sloan Kettering Cancer Center; and 4Division of Hematology/Oncology, Columbia University Medical Center, New York, New York 1Laboratory of New Drug Development, Division of Solid Tumor Oncology, Department of Medicine, *Laboratory of New Drug Development, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021; and Authors' Affiliations: Departments of 1Medicine, 2Molecular Pharmacology and Chemistry, and 3Surgery, Memorial Sloan-Kettering Cancer Center, New York 2Melanoma/Sarcoma Service, Laboratory of New Drug Development and All authors: Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY From the Division of Cancer Treatment and Diagnosis (A.P. Chen, E.S., G.O.-C., N.M., J.C.F., A.R.N., N.T., L.K.F., C.L.R., J.H.D.) and the Center for Cancer Research (J.G., J.H.D.), National Cancer Institute, Bethesda, the Clinical Pharmacodynamics Biomarker Program, Applied and Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick (K.K.F., B.L.M., D.F.W., A.B., K.V.F.-G., R.E.P.), and the Department of Oncology, Johns Hopkins University School of Medicine... Authors' Affiliations: Departments of 1Medicine and 2Pathology, 3Molecular Pharmacology and Chemistry Program, Sloan Kettering Institute, 4Laboratory of New Drug Development, Memorial Sloan-Kettering Cancer Center, New York; and 5Department of Medicine, Tufts Medical Center, Boston, Massachusetts; Authors' Affiliations: Departments of 1Medicine and 2Pathology, 3Molecular Pharmacology and Chemistry Program, Sloan Kettering Institute, 4Laboratory of New Drug Development, Memorial Sloan-Kettering Cancer Center, New York; and 5Department of Medicine, Tufts Medical Center, Boston, Massachusetts Division of Hematology and Oncology, Department of Medicine, Columbia University, New York, New York, USA Division of Hematology and Medical Oncology, Department of Medicine, Columbia University Irving Medical Center, New York, NY Mrinal M. Gounder, William D. Tap, Mark A. Dickson, Mary Louise Keohan, Sandra P. D'Angelo, Mercedes Condy, Lanier Tanner, Joseph P. Erinjeri, and Francis H. Jasmine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; Gary K. Schwartz, Columbia University Medical Center, New York, NY; Alona Zer, Samer Salah, Abha A. Gupta, Herbert H. Loong, Stephanie Baker, Kjirsten Nyquist-Schultz, and Albiruni Ryan Abdul Razak, Princess Margaret Cancer Center, Toronto, Ontario, Canada; and Sharon... for the COVID-19 and Cancer Consortium Laboratory of New Drug Development Memorial Sloan‐Kettering Cancer Center (MSKCC) New York NY USA; Division of Hematology/Oncology Columbia University Medical Center Chicago New York, NY USA Authors' Affiliations: 1Department of Neurology; 2Cyclotron and Radiochemistry Core Facility; 3Department of Medicine, Laboratory of New Drug Development; 4Sloan Kettering Institute Molecular Pharmacology and Chemistry Program, and 5Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York; and 6Departments of Medicine and Pharmacology, CINJ, RWJMS, UMDNJ, Newark, New Jersey Case Comprehensive Cancer Center Case Western Reserve University Cleveland Ohio USA Authors' Affiliations: 1Ludwig Center for Cancer Immunotherapy, Immunology Program, Sloan-Kettering Institute, Departments of 2Epidemiology and Biostatistics and 3Medicine, Memorial Sloan Kettering Cancer Center, New York, New York 1Medicine, Departments of 3Memorial Sloan Kettering Cancer Center, New York, New York. Department of Medicine, Columbia University Medical Center, New York, New York, USA; Herbert Irving Comprehensive Cancer Center, Columbia University College of Medicine, New York, New York, USA Herbert Irving Comprehensive Cancer Center, New York, NY, USA; Department of Hematology/Oncology, Columbia University College of Medicine, New York, NY, USA Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, USA; Current address: Columbia University, New York, USA From the Division of Hematology and Oncology, Columbia University School of Medicine, Herbert Irving Comprehensive Cancer Center, New York, NY; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY; Program in Molecular Biology, Memorial Sloan Kettering Cancer Center, New York, NY. Jennifer Goodman Linn Laboratory of New Drug Development; Department of Medicine; Memorial Sloan-Kettering Cancer Center; New York, NY USA Herbert Irving Comprehensive Cancer Center Columbia University New York NY, USA USA From the Dana-Farber Cancer Institute; Massachusetts General Hospital; Ludwig Center at Dana-Farber/Harvard Cancer Center, Boston, MA; and the Memorial Sloan-Kettering Cancer Center, New York, NY. 1Department of Medicine, Division of Solid Tumor Oncology, Gastrointestinal Oncology Service,; 2Departments of Biostatistics, Gary K. Schwartz, Herbert Irving Comprehensive Cancer Center, New York; and Robert G. Maki, Northwell Health, Great Neck, NY Columbia University School of Medicine, New York, NY 12Columbia University, New York, New York. From the Memorial Sloan-Kettering Cancer Center, New York, NY; and the University of Pittsburgh Cancer Institute, Pittsburgh, PA From the Gastrointestinal Oncology Service and Developmental Chemotherapy Service, Department of Medicine and Department of Biostatistics and Epidemiology, Memorial Sloan-Kettering Cancer Center, New York, NY; Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT; and Investigational Drug Branch, Clinical Trials Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD From the Gastrointestinal Oncology Service and Departments of Medicine, Pathology, and Diagnostic Imaging, Memorial Sloan-Kettering Cancer Center, New York, NY Herbert Irving Comprehensive Cancer Center Columbia University New York New York USA Authors' Affiliations: 1Melanoma and Sarcoma Service, Department of Medicine; 2Biostatistics Service, Department of Epidemiology and Biostatistics; Memorial Sloan-Kettering Cancer Center, New York, New York; and 3Department of Molecular Cell Biology, Georgia Institute of Technology, Atlanta, Georgia 2Medicine, and Herbert Irving Comprehensive Cancer Center of Columbia University, New York, NY, USA; Division of Hematology/Oncology, Columbia University Irving Medical Center, New York, NY, USA From the Department of Medicine, Division of Solid Tumor Oncology, Gastrointestinal Oncology Service; and the Laboratory of New Drug Development, Memorial Sloan-Kettering Cancer Center, New York, NY Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA; Department of Medicine, Division of Hematology/Oncology, Columbia University Medical Center, New York, NY, USA 1Laboratory of New Drug Development, Department of Medicine and From the Division of Solid Tumor Oncology, Department of Medicine; Department of Finance; and Department of Biostatistics, Memorial Sloan-Kettering Cancer Center, New York; the Departments of Public Health and Medicine, Cornell University Medical College, New York, NY; and the Divisions of Population Science and Medical Science, Fox Chase Cancer Center, Philadelphia, PA (E.J.S.'s current affiliation). 1Department of Medicine, Columbia University Medical Center, New York, New York.; 2Herbert Irving Comprehensive Cancer Center, Columbia University College of Medicine, New York, New York. 3Laboratory of New Drug Development, Department of Medicine, and Memorial Sloan-Kettering Cancer Center, New York, New York2Weill Medical College of Cornell University, New York, New York 1The Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York.; 3Division of Hematology/Oncology, Columbia University Medical Center, New York, New York. Columbia University, New York, NY, USA Chemistry Department, Brooklyn College and The Graduate Center, The City University of New York, Brooklyn, New York 11210, Chemistry Center, Instituto Venezolano de Investigaciones Científicas, IVIC, Caracas 1020-A (Venezuela), Muséum National d’Histoire Naturelle, USM 504 Biologie fonctionnelle des Protozoaires, EA 3335, 75231 PARIS Cedex 05, France, Institut de Médecine Tropicale du Service de Santé des Armées (IMTSSA), UMR-MD3 Relations Hôte-Parasites, Pharmacologie et Thérapeutique, Université de la... 1Medicine, Division of Solid Tumor Oncology, Gastrointestinal Oncology Service, Departments of; 4Laboratory of New Drug Development Memorial Sloan Kettering Cancer Center, New York, New York 1Laboratory of New Drug Development, Department of Medicine, and Herbert Irving Comprehensive Cancer Center, Columbia University, New York, New York The Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY, USA |
Incoming Links
Showing number of triples: 1 to 383 of 383.